nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—ADRA1D—Amine ligand-binding receptors—HRH3—narcolepsy	0.0219	0.0219	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Other—P2RY11—narcolepsy	0.0205	0.0205	CbGpPWpGaD
Alfuzosin—ADRA1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0182	0.0182	CbGpPWpGaD
Alfuzosin—ADRA1B—AMPK Signaling—CPT1B—narcolepsy	0.017	0.017	CbGpPWpGaD
Alfuzosin—ADRA1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0162	0.0162	CbGpPWpGaD
Alfuzosin—ADRA1A—AMPK Signaling—CPT1B—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Alfuzosin—ADRA1D—Monoamine GPCRs—HTR2A—narcolepsy	0.013	0.013	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—P2RY11—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Alfuzosin—ADRA1D—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Alfuzosin—ADRA1B—Monoamine GPCRs—HTR2A—narcolepsy	0.0108	0.0108	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00991	0.00991	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00991	0.00991	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—HCRT—narcolepsy	0.00981	0.00981	CbGpPWpGaD
Alfuzosin—ADRA1A—Monoamine GPCRs—HTR2A—narcolepsy	0.0096	0.0096	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—P2RY11—narcolepsy	0.00957	0.00957	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00923	0.00923	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00923	0.00923	CbGpPWpGaD
Alfuzosin—ADRA1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00908	0.00908	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00892	0.00892	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00881	0.00881	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00881	0.00881	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00877	0.00877	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00867	0.00867	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00856	0.00856	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.0085	0.0085	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—HCRT—narcolepsy	0.00814	0.00814	CbGpPWpGaD
Alfuzosin—ADRA1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00807	0.00807	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00791	0.00791	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00791	0.00791	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00788	0.00788	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00788	0.00788	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00766	0.00766	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00766	0.00766	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00764	0.00764	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00761	0.00761	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—TRH—narcolepsy	0.00743	0.00743	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0074	0.0074	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00728	0.00728	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—HCRT—narcolepsy	0.00723	0.00723	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00681	0.00681	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00681	0.00681	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00665	0.00665	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00657	0.00657	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00657	0.00657	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00657	0.00657	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0065	0.0065	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00647	0.00647	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00634	0.00634	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—TRH—narcolepsy	0.00617	0.00617	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00602	0.00602	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00602	0.00602	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00583	0.00583	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00583	0.00583	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—P2RY11—narcolepsy	0.00582	0.00582	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00579	0.00579	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Other—HTR2A—narcolepsy	0.00578	0.00578	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00563	0.00563	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00552	0.00552	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.00548	0.00548	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—NPS—narcolepsy	0.0054	0.0054	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—TAC1—narcolepsy	0.0054	0.0054	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00539	0.00539	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00522	0.00522	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00504	0.00504	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HCRTR2—narcolepsy	0.005	0.005	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HCRTR1—narcolepsy	0.005	0.005	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HCRT—narcolepsy	0.00495	0.00495	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00492	0.00492	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0049	0.0049	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00483	0.00483	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00483	0.00483	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—P2RY11—narcolepsy	0.00483	0.00483	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00481	0.00481	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00479	0.00479	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—TAC1—narcolepsy	0.00448	0.00448	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—NPS—narcolepsy	0.00448	0.00448	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00444	0.00444	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00444	0.00444	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—PENK—narcolepsy	0.00441	0.00441	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00432	0.00432	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00429	0.00429	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00427	0.00427	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00418	0.00418	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HCRT—narcolepsy	0.00411	0.00411	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00409	0.00409	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00398	0.00398	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00398	0.00398	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—TRH—narcolepsy	0.00375	0.00375	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00371	0.00371	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—PENK—narcolepsy	0.00366	0.00366	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00365	0.00365	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00358	0.00358	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00358	0.00358	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00358	0.00358	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00356	0.00356	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00356	0.00356	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HRH3—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00325	0.00325	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—HTR2A—narcolepsy	0.00325	0.00325	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00309	0.00309	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00309	0.00309	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—P2RY11—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00283	0.00283	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00283	0.00283	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HCRT—narcolepsy	0.0028	0.0028	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00276	0.00276	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—NPS—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—TAC1—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00242	0.00242	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00242	0.00242	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.0024	0.0024	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.00226	0.00226	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.00226	0.00226	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.00226	0.00226	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.00212	0.00212	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.00211	0.00211	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.00186	0.00186	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.000997	0.000997	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.000985	0.000985	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.000943	0.000943	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000926	0.000926	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.000841	0.000841	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000838	0.000838	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.000827	0.000827	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000826	0.000826	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000826	0.000826	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000769	0.000769	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000735	0.000735	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CHKB—narcolepsy	0.000724	0.000724	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000698	0.000698	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.000685	0.000685	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.000685	0.000685	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000683	0.000683	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.00062	0.00062	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000609	0.000609	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000609	0.000609	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.000497	0.000497	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000492	0.000492	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.000412	0.000412	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000366	0.000366	CbGpPWpGaD
